Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor

Annals of Oncology

Volumn 21, Issue 9, 2010, Pages 1846-1850

  Ehrlich, Y ^a   Beck, S D W ^a   Ulbright, T M ^a   Cheng, L ^a   Brames, M J ^a   Andreoiu, M ^a   Foster, R S ^a   Einhorn, L H ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Lance Armstrong Foundation ^*  (United States)

Author keywords

Primitive neuroectodermal tumor; Teratoma; Testicular neoplasia

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; TOPOTECAN; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURGERY; CHROMOSOME TRANSLOCATION; EWING SARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GERM CELL TUMOR; HUMAN; INOPERABLE CANCER; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS; MULTIPLE CYCLE TREATMENT; NEUROECTODERM TUMOR; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PATIENT SELECTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; TERATOMA; TREATMENT INDICATION; TREATMENT RESPONSE;

EID: 77956096193     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq045     Document Type: Article

References (21)

1. Ulbright TM, Loehrer PJ, Roth LM et al. The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer 1984; 54: 1824-1833.
2. Ahmed T, Bosl GJ, Hajdu SI. Teratoma with malignant transformation in germ cell tumors in men. Cancer 1985; 56: 860-863.
3. Little JS Jr., Foster RS, Ulbright et al. Unusual neoplasms detected in testis cancer patients undergoing post-chemotherapy retroperitoneal lymphadenectomy. J Urol 1994; 152: 1144-1149.
4. Comiter CV, Kibel AS, Richie JP et al. Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol 1998; 159: 859-863.
5. Motzer RJ, Amsterdam A, Prieto V et al. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol 1998; 159: 133-138.
6. Ganjoo KN, Foster RS, Michael H et al. Germ cell tumor associated primitive neuroectodermal tumors. J Urol 2001; 165: 1514-1516.
7. Loehrer PJ Sr, Hui S, Clark S et al. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation. J Urol 1986; 135: 1183-1189.
8. Lutke Holzik MF, Hoekstra HJ, Mulder NH et al. Non-germ cell malignancy in residual or recurrent mass after chemotherapy for nonseminomatous testicular germ cell tumor. Ann Surg Oncol 2003; 10: 131-135.
9. Spiess PE, Pisters LL, Liu P et al. Malignant transformation of testicular teratoma: a chemoresistant phenotype. Urol Oncol 2008; 26: 595-599.
10. Carver BS, Shayegan B, Serio A et al. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. J Clin Oncol 2007; 25: 1033-1037.
11. de Alava E, Gerald WL. Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family. J Clin Oncol 2000; 18: 204-213.
12. Michael H, Hull MT, Ulbright TM et al. Primitive neuroectodermal tumors arising in testicular germ cell neoplasms. Am J Surg Pathol 1997; 21: 896-904.
13. Donadio AC, Motzer RJ, Bajorin DF et al. Chemotherapy for teratoma with malignant transformation. J Clin Oncol 2003; 21: 4285-4291.
14. El Mesbahi O, Terrier-Lacombe MJ, Rebischung C et al. Chemotherapy in patients with teratoma with malignant transformation. Eur Urol 2007; 51: 1306-1311.
15. Grier HE, Krailo MD, Tarbell NJ et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348: 694-701.
16. Rossi A, Caracciolo V, Russo G et al. Medulloblastoma: from molecular pathology to therapy. Clin Cancer Res 2008; 15: 971-976.
17. Kernek KM, Brunelli M, Ulbright TM et al. Fluorescence in situ hybridization analysis of chromosome 12p in paraffin-embedded tissue is useful for establishing germ cell origin of metastatic tumors. Mod Pathol 2004; 17: 1309-1313.
18. Leibovitch I, Foster RS, Ulbright TM et al. Adult primary pure teratoma of the testis. The Indiana experience. Cancer 1995; 75: 2244-2250.
19. Kernek KM, Ulbright TM, Zhang S et al. Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis. Am J Pathol 2003; 163: 2477-2484.
20. van Echten J, van der Vloedt WS, van de Pol M et al. Comparison of the chromosomal pattern of primary testicular nonseminomas and residual mature teratomas after chemotherapy. Cancer Genet Cytogenet 1997; 99: 59-67.
21. Ehrlich Y, Brames JM, Beck SDW et al. Long-term follow-up of cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a post-chemotherapy retroperitoneal lymph node dissection needed following complete remission? J Clin Oncol 2010; 28: 531-536.